Canoe Financial LP Purchases 6,439 Shares of Equifax, Inc. $EFX

Key Points

• Canoe Financial LP significantly increased its holdings in Equifax, Inc. by 435.7% in Q2, now owning 7,917 shares valued at approximately $2.05 million.
• Equifax reported a Q2 earnings per share (EPS) of $2.00, surpassing the consensus estimate of $1.92, and indicated a revenue of $1.54 billion.
• The company declared a quarterly dividend of $0.50, representing an annualized yield of 0.8% with a payout ratio of 39.14%.

Canoe Financial LP grew its holdings in Equifax, Inc. (NYSE:EFX - Free Report) by 435.7% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 7,917 shares of the credit services provider's stock after acquiring an additional 6,439 shares during the quarter. Canoe Financial LP's holdings in Equifax were worth $2,053,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Ameriflex Group Inc. bought a new stake in Equifax in the 4th quarter valued at about $28,000. N.E.W. Advisory Services LLC bought a new position in shares of Equifax during the first quarter worth approximately $28,000. Zions Bancorporation National Association UT acquired a new stake in shares of Equifax in the first quarter valued at approximately $32,000. City Holding Co. bought a new stake in shares of Equifax in the first quarter valued at approximately $34,000. Finally, ST Germain D J Co. Inc. bought a new stake in shares of Equifax in the first quarter valued at approximately $38,000. 96.20% of the stock is owned by institutional investors.

Equifax Stock Performance

NYSE:EFX opened at $260.90 on Friday. Equifax, Inc. has a twelve month low of $199.98 and a twelve month high of $307.08. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.79. The stock's 50-day simple moving average is $248.82 and its 200 day simple moving average is $250.68. The firm has a market capitalization of $32.30 billion, a PE ratio of 51.06, a price-to-earnings-growth ratio of 3.16 and a beta of 1.68.

Equifax (NYSE:EFX - Get Free Report) last issued its earnings results on Tuesday, July 22nd. The credit services provider reported $2.00 EPS for the quarter, topping the consensus estimate of $1.92 by $0.08. The firm had revenue of $1.54 billion during the quarter, compared to the consensus estimate of $1.51 billion. Equifax had a return on equity of 18.89% and a net margin of 10.95%.The business's quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.82 earnings per share. Equifax has set its Q3 2025 guidance at 1.870-1.970 EPS. FY 2025 guidance at 7.330-7.630 EPS. On average, analysts anticipate that Equifax, Inc. will post 7.58 EPS for the current fiscal year.

Equifax Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, September 15th. Investors of record on Tuesday, September 2nd were paid a $0.50 dividend. The ex-dividend date of this dividend was Tuesday, September 2nd. This represents a $2.00 annualized dividend and a yield of 0.8%. Equifax's dividend payout ratio is presently 39.14%.

Insiders Place Their Bets

In other Equifax news, CEO Mark W. Begor sold 48,264 shares of the business's stock in a transaction on Monday, July 28th. The shares were sold at an average price of $241.71, for a total transaction of $11,665,891.44. Following the sale, the chief executive officer owned 142,872 shares of the company's stock, valued at approximately $34,533,591.12. The trade was a 25.25% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.40% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

EFX has been the topic of a number of recent research reports. Oppenheimer lowered their price objective on Equifax from $296.00 to $279.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 23rd. Citigroup reduced their target price on Equifax from $294.00 to $290.00 and set a "buy" rating on the stock in a report on Wednesday, July 23rd. Royal Bank Of Canada restated an "outperform" rating and issued a $300.00 price target on shares of Equifax in a research report on Wednesday, June 18th. Robert W. Baird cut their price objective on shares of Equifax from $310.00 to $289.00 and set an "outperform" rating for the company in a research report on Wednesday, July 23rd. Finally, UBS Group increased their price objective on shares of Equifax from $287.00 to $297.00 and gave the stock a "buy" rating in a research note on Monday. One investment analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and six have issued a Hold rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $284.80.

Equifax Company Profile

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.

Want to see what other hedge funds are holding EFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Equifax, Inc. (NYSE:EFX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.